Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 8 Stomach Neoplasms 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Carcinoma, Renal Cell 3 Recurrence 2 Neoplasm Metastasis 2 Melanoma 2 Kidney Neoplasms 2 Esophageal Neoplasms 2 Cholangiocarcinoma 2 Adenocarcinoma Of Esophagus 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Solid Tumors 1 Solid Tumor 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Metastatic Urothelial Cancer 1

Interventions

Capecitabine 41 Oxaliplatin 39 Fluorouracil 29 Leucovorin 23 Radiotherapy 21 Cetuximab 14 Bevacizumab 14 Irinotecan 13 Nivolumab 12 Magnetic Resonance Spectroscopy 11 Specimen Handling 9 Surgical Procedures, Operative 8 Folfox protocol 8 Drug Therapy 8 pembrolizumab 7 Radiotherapy, Intensity-Modulated 7 Chemoradiotherapy 7 Biopsy 7 trifluridine tipiracil drug combination 6 Radiation 6 tislelizumab 5 sintilimab 5 regorafenib 5 dehydroftorafur 5 X-Rays 5 Surveys and Questionnaires 5 Sigmoidoscopy 5 Endoscopy 5 Consolidation Chemotherapy 5 spartalizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rectal Neoplasms × zimberelimab × 1 year × Clear all

NCT05024097 2025-08-27

PANTHER

Weill Medical College of Cornell University

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡